| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/24/2003 | US20030077594 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 04/24/2003 | US20030077593 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077583 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077565 Preservation of corneal graft in vitro; obtain graft, incubate with antisense oligonucleotides in solution, monitor viability of graft tissue |
| 04/24/2003 | US20030077564 Amplification of neural cell viability in brain or spinal cord tissue after brain or spinal cord injury; obtain tissue, apply nutrient broth, monitor cell viability |
| 04/24/2003 | US20030077318 Activation lymphocytes; therapy for aids, cancer; immobilization on solid support |
| 04/24/2003 | US20030077281 Immunointeractive molecules and uses therefor |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077277 Human antibodies that have MN binding and cell adhesion-neutralizing activity |
| 04/24/2003 | US20030077263 Method of activating dendritic cells |
| 04/24/2003 | US20030077260 Hybrid matrix implants and explants |
| 04/24/2003 | US20030077259 Induction of beta cell differentiation in human cells |
| 04/24/2003 | US20030077258 Comprising one or more chondroitin sulfate proteoglycan (CSPG)-degrading enzymes that promote axonal penetration into damaged nerve tissue and nerve graft |
| 04/24/2003 | US20030077256 Pancreas regeneration using embryonic pancreatic cells |
| 04/24/2003 | US20030077250 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene |
| 04/24/2003 | US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer |
| 04/24/2003 | US20030077248 Treating cancer with a culture product from a non-naturally occurring antigen-presenting cell; polyclonal antibodies expression |
| 04/24/2003 | US20030077247 Chemokines as adjuvants of immune response |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | US20030077226 Cleaving the beta secretase cleavage site of the amyloid precursor protein |
| 04/24/2003 | US20030075187 Mixed chimerism and tolerance |
| 04/24/2003 | CA2775218A1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 04/24/2003 | CA2463979A1 Method of producing human beta cell lines |
| 04/24/2003 | CA2463943A1 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/24/2003 | CA2463927A1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | CA2463925A1 Bone anti-resorptive compounds |
| 04/24/2003 | CA2463916A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/24/2003 | CA2463914A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 04/24/2003 | CA2463816A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/24/2003 | CA2463672A1 Direct targeting binding proteins |
| 04/24/2003 | CA2463573A1 Article dispensing apparatus and method |
| 04/24/2003 | CA2463492A1 Methods for the treatment of carcinoma |
| 04/24/2003 | CA2463473A1 Targeted therapeutic proteins |
| 04/24/2003 | CA2463003A1 Dimerized growth factor and materials and methods for producing it |
| 04/24/2003 | CA2462785A1 Kinases and phosphatases |
| 04/24/2003 | CA2462588A1 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 04/24/2003 | CA2462447A1 Article handling system and method |
| 04/24/2003 | CA2461818A1 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | CA2457821A1 Coffee plant with reduced .alpha.-d-galactosidase activity |
| 04/24/2003 | CA2454578A1 Modified human thymic stromal lymphopoietin |
| 04/24/2003 | CA2452797A1 Apparatus and method for mixing specimens in vials |
| 04/23/2003 | EP1304382A2 Production of peptides in plants as viral coat protein fusions |
| 04/23/2003 | EP1304379A2 Humanised antibody against CD18 |
| 04/23/2003 | EP1304378A1 ARL-2 for fertility control |
| 04/23/2003 | EP1304119A2 Method for preventing and treating hearing loss using a neurturin protein product |
| 04/23/2003 | EP1304113A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1304112A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1303620A2 Regulation of human desc1-like serine protease |
| 04/23/2003 | EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 04/23/2003 | EP1303614A2 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 04/23/2003 | EP1303613A2 Rescue of canine distemper virus from cdna |
| 04/23/2003 | EP1303612A2 Streptococcus antigens |
| 04/23/2003 | EP1303611A2 Novel protein containing ring finger domaine r1p4 |
| 04/23/2003 | EP1303610A2 Extracellular matrix protein |
| 04/23/2003 | EP1303609A2 G-protein coupled receptors |
| 04/23/2003 | EP1303608A2 Zinc finger domain recognition code and uses thereof |
| 04/23/2003 | EP1303607A2 High affinity soluble interleukin-18 receptor |
| 04/23/2003 | EP1303606A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 04/23/2003 | EP1303604A2 Mammalian receptor proteins; related reagents and methods |
| 04/23/2003 | EP1303602A2 Soluble zalpha11 cytokine receptors |
| 04/23/2003 | EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/23/2003 | EP1303599A2 Methylated nucleotide regulation of upa gene expression |
| 04/23/2003 | EP1303594A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 04/23/2003 | EP1303589A1 Pre-adipose cell lines |
| 04/23/2003 | EP1303588A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 04/23/2003 | EP1303587A2 Synchronised arabidopsis cell suspensions and uses thereof |
| 04/23/2003 | EP1303586A1 Dna/rna-embedding medium and method of use |
| 04/23/2003 | EP1303539A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303530A2 CLONING AND PRODUCING THE N. i Bst /i NBI NICKING ENDONUCLEASE AND RELATED METHODS FOR USING NICKING ENDONUCLEASES IN SINGLE-STRANDED DISPLACEMENT AMPLIFICATION |
| 04/23/2003 | EP1303183A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 04/23/2003 | EP1250055A4 Immune modulation with death receptor-induced apoptosis |
| 04/23/2003 | EP1235842A4 Rna interference pathway genes as tools for targeted genetic interference |
| 04/23/2003 | EP1028738B1 Use of cytokines and mitogens to inhibit pathological immune responses |
| 04/23/2003 | EP1019503A4 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 04/23/2003 | EP0961827A4 Mammalian and human rec2 |
| 04/23/2003 | EP0730639B1 Cell separation device |
| 04/23/2003 | EP0714439B1 Recombinant humanized anti-human immunodeficiency virus antibody |
| 04/23/2003 | EP0672145B1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2003 | CN1413257A Trans-species transfer of apoptotic genes and transgenic plants developed thereby |
| 04/23/2003 | CN1413254A Maize MIP synthase promoter |
| 04/23/2003 | CN1413252A 新型酶 The new enzyme |
| 04/23/2003 | CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/23/2003 | CN1413249A Human heparanase-related polypeptide and nucleic acid |
| 04/23/2003 | CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/23/2003 | CN1413220A Anti-prostate stem cell antigen (PSCA) antibody compositions and method of use |
| 04/23/2003 | CN1413219A Molecular structure of RHD negative genes locus |
| 04/23/2003 | CN1412310A Enzyme with protease activity |
| 04/23/2003 | CN1412302A Method for preparing transfer mitochondrial genome mouse |
| 04/23/2003 | CN1412301A Cell freeze-storing liquor for raising anabiosis rate of freeze-stored cell |
| 04/23/2003 | CN1412295A Oncolytic microorganism expressing heat shock protein and its application |
| 04/23/2003 | CN1412201A Monoclonal antibody for resisting human liver cancer and its application |
| 04/23/2003 | CN1106446C Cell culture method for tobacco for producing nicotine |
| 04/23/2003 | CN1106203C Chlamydia vaccine and process |
| 04/22/2003 | US6552246 Marker sequence has been substituted for at least intron 6 and exon 6, and wherein disruption prevents expression of CD45 on B-cells and T-cells and results in a decreased cytotoxic T-cell response |
| 04/22/2003 | US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof |